last year amount of 37.34 million Baht or decreased 55.06%. In 2019 the Company has received the doubtful debt 2.79 million Baht, decreased from the same period of last year amount of 30.17 million Baht

the money market fluctuation during COVID-19. Besides, the Company had interest bearing debt of THB 41,381.8 mm, which increased by THB 2,157.5 mm from THB 39,224.3 mm. However, the weighted 82,263.8

Q2 2023 Return on equity (ROE) 12.0% 13.5% 17.1% 20.1% 20.7% 20.3% Return on asset (ROA) 4.4% 5.0% 6.5% 7.7% 8.1% 8.1% Interest bearing Debt / Equity (IBD/Equity) 0.8 0.8 0.8 0.8 0.7 0.6 Return on

ratios stood at 68.47% and 72.47%, respectively. The higher ratio on a year-on-year basis was attributable to the Company having some costs in depreciation, personnel, drugs and medical supplies

March 31, 2019, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 64.85% and 66.03%, respectively. The higher ratio on a period-on-period basis was attributable to the

six-month period ended June 30, 2020, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 68.97% and 72.06% , respectively. The higher ratio on a period-on-period basis

. Meanwhile, the cost of hospital operations to revenue ratios stood at 66.03% and 67.73%, respectively. The higher ratio on a period-on-period basis was attributable to the Company having some costs in

third quarter 2020, the Company has net profit equivalent to Baht 4.13 million, increasing from the same period of previous year by Baht 4.70 million which net profit margin ratio was 1.80%. For 9-month

ordinary shares and the exercise ratio to purchase the ordinary shares, including the method to calculate the said adjustments, as described hereinafter shall not subordinate any returns, which the warrant

by Baht 8 .39 million; this mainly comes from 1 .The group recovered bad debt in 2017 of Baht 3.62 million which leads to expense decreasing in 2017. However, there is no recovered bad debt in 2018. 2